Results 151 to 160 of about 471,786 (305)

Towards Credible GHG Reporting: The Role of GHG Assurance and Assurance Providers in Firm Valuation

open access: yesAbacus, EarlyView.
The demand for greenhouse gas (GHG) emissions disclosures is rising globally; yet, the credibility of such information remains uncertain when assurance is not mandated. Drawing on a sample of firms from 43 countries, this study examines the role of GHG assurance and the choice of assurance provider in the market value effects of GHG emissions.
Sudipta Bose   +2 more
wiley   +1 more source

From a Gene Mutation to Pathology and Targeted Therapy in a Patient with Therapy-resistant Porokeratosis. [PDF]

open access: yesActa Derm Venereol
Möller M   +4 more
europepmc   +1 more source

Running towards: Labour market incentives for runaway slaves in the British Cape Colony, 1830–1838

open access: yesAsia‐Pacific Economic History Review, EarlyView.
Abstract Recent scholarship on slave escapes has increasingly emphasised economic motivation, but few studies have empirically investigated how market incentives influenced the decision‐making of enslaved individuals during transitions from coerced to wage labour.
Karl Bergemann   +2 more
wiley   +1 more source

Welt

open access: yes, 2012
Source: Karl Henckell: Gesammelte Werke. Erste kritische Ausgabe eigener Hand, Band 1: Buch des Lebens, Band 2: Buch des Kampfes, München: Müller, 1921.
Werron, Tobias   +6 more
openaire   +3 more sources

A Straightforward Algorithm for Diagnosing Hymenoptera Venom Allergy and Identifying the Relevant Venom for Immunotherapy

open access: yesAllergy, EarlyView.
Conventional tests, such as specific IgE (sIgE) or intradermal testing (IDT), are usually sufficient. Combining both tests increases sensitivity, while additional tests, like the basophil activation test (BAT), provide no further benefit for the majority of patients.
Lisa Arzt‐Gradwohl   +8 more
wiley   +1 more source

Symptomatic Left Main Coronary Artery Aneurysm With Intraluminal Thrombus. [PDF]

open access: yesAnn Thorac Surg Short Rep
DiChiacchio L   +4 more
europepmc   +1 more source

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria

open access: yesAllergy, EarlyView.
Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...
Ana M. Gimenez‐Arnau   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy